<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Plasma CXCL1 levels and TRAF3IP2 variants in patients with myocardial infarction</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><forename type="first">Safoora</forename><surname>Pordel</surname></persName>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">Shiraz University of Medical Sciences</orgName>
								<address>
									<settlement>Shiraz</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Mahdi</surname></persName>
						</author>
						<author>
							<persName><forename type="first">Sajedi</forename><surname>Khanian</surname></persName>
							<affiliation key="aff1">
								<orgName type="department" key="dep1">Department of Cardiology</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">Shiraz University of Medical Sciences</orgName>
								<address>
									<settlement>Shiraz</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Mohammad</forename><forename type="middle">Hossein</forename><surname>Karimi</surname></persName>
							<affiliation key="aff2">
								<orgName type="department">Fars Blood Transfusion Center</orgName>
								<address>
									<settlement>Shiraz</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">Hossein</forename><surname>Nikoo</surname></persName>
							<affiliation key="aff3">
								<orgName type="institution" key="instit1">Cardiovascular Research Center</orgName>
								<orgName type="institution" key="instit2">Shiraz University of Medical Sciences</orgName>
								<address>
									<settlement>Shiraz</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
							<affiliation key="aff4">
								<orgName type="department">Department of Immunology</orgName>
								<orgName type="laboratory">Memory T cell Laboratory</orgName>
								<orgName type="institution">Correspondence Mehrnoosh Doroudchi</orgName>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department">School of Medicine</orgName>
								<orgName type="institution">Shiraz University of Medical Science</orgName>
								<address>
									<settlement>Shiraz</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><forename type="first">|</forename><surname>Mehrnoosh Doroudchi</surname></persName>
							<idno type="ORCID">0000-0003-4067-5400</idno>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">School of Medicine</orgName>
								<orgName type="institution">Shiraz University of Medical Sciences</orgName>
								<address>
									<settlement>Shiraz</settlement>
									<country key="IR">Iran</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff6">
								<orgName type="institution">Shiraz University of Medical Sciences</orgName>
								<address>
									<settlement>Grant</settlement>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Plasma CXCL1 levels and TRAF3IP2 variants in patients with myocardial infarction</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">037A80E70A7110D9CE68FE2E5E136619</idno>
					<idno type="DOI">10.1002/jcla.22402</idno>
					<note type="submission">Received: 6 December 2017 | Accepted: 13 January 2018</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:32+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<textClass>
				<keywords>
					<term>Act1, actin-related protein 1</term>
					<term>CRP, C-reactive protein</term>
					<term>ELISA, enzyme-linked immunosorbent assay</term>
					<term>HDL, high-density lipoprotein</term>
					<term>IL-17A, interleukin 17A</term>
					<term>LDL, low-density lipoprotein</term>
					<term>MI, Myocardial infarction</term>
					<term>MMP, matrix metalloproteinases</term>
					<term>PCR, polymerase chain reaction</term>
					<term>RFLP, restriction fragment length polymorphism</term>
					<term>SNP, single nucleotide polymorphism</term>
					<term>TG, triglyceride</term>
					<term>Th, T-helper</term>
					<term>TNF, tumor necrosis factor CXCL1, IL-17A, myocardial infarction, TRAF3IP2</term>
				</keywords>
			</textClass>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Myocardial infarction (MI) is one of the chief causes of death worldwide.</s><s>Inflammatory responses have been confirmed to be the hallmarks of MI. 1 Indeed, MI leads to an intricate inflammatory reaction accompanied by cytokine secretion and recruitment of inflammatory cells into the infarcted myocardial region. 2,3</s><s>Among cytokines, IL-17A triggers the production and activation of chemokines, inflammatory cytokines, matrix metalloproteinases (MMPs), and caspases 3 and 9 that cause apoptosis in endothelial cells and cardiomyocytes. <ref type="bibr" target="#b4">4</ref></s><s>Increased frequency of Th17 cells and excessive production of IL-17, IL-6, IL-23 are demonstrated in patients with acute myocardial infarction (AMI). <ref type="bibr" target="#b5">5,</ref><ref type="bibr" target="#b6">6</ref></s><s>In addition, percutaneous coronary intervention (PCI), which is a common therapeutic intervention to attenuate</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>8]<ref type="bibr" target="#b9">[9]</ref> IL-17A receptor consists of IL-17RA and IL-17RC chains where binding of IL-17A induces the onset of downstream signaling pathways through recruitment of Act1 adaptor molecule.</s><s>Act1 eventually activates several transcription factors and transcription of chemokines, cytokines, and MMPs.</s><s>Enhanced IL-17A signaling via the activation of a number of mitogen-activated protein kinases (MAPK) causes elevated expression of downstream proinflammatory targets.</s><s>In addition, IL-17A signaling may cause Act1 interaction with TNF receptor-associated factor 2 (TRAF2) and TRAF5 and lead to increased stability of CXCL1 mRNA.</s><s>Thus, the inflammatory and pro-atherogenic function of IL-17A can be aggravated. <ref type="bibr" target="#b10">10,</ref><ref type="bibr" target="#b11">11</ref></s><s>Act1deficient mice models have revealed that Act1-dependent IL-17 signaling pathway is pivotal for pathogenesis of EAE, <ref type="bibr" target="#b12">12</ref> collageninduced arthritis (CIA), and colitis. <ref type="bibr" target="#b13">13,</ref><ref type="bibr" target="#b14">14</ref></s><s>Previous reports reveal that the rs33980500 and rs13210247 SNPs in TRAF3IP2 gene are markedly associated with inflammatory diseases. <ref type="bibr" target="#b15">15,</ref><ref type="bibr" target="#b16">16</ref></s><s>According to the role of IL-17A signals in augmentation of inflammatory conditions and its link to the pathogenesis of MI, we hypothesized that polymorphisms in Act1, the key adaptor molecule in IL-17A signaling pathway, are correlated with myocardial infarction or its outcome in patients.</s><s>Selection of polymorphisms was based on a thorough search on all validated SNPs within TRAF3IP2 gene in NCBI databases.</s><s>Based on previous studies, the rs33980500 SNP affects downstream signaling by altering the expression of protein (Act1), and along with rs13210247 is associated with several inflammatory diseases.</s><s>Therefore, we studied both SNPs in the TRAF3IP2 adaptor (Act1) gene in patients who were hospitalized because of myocardial infarction.</s><s>The SNP frequencies were also defined in a group of healthy blood donors in the same geographic region.</s><s>Since previous studies have shown that certain genotypes of rs33980500 from TRAF3IP2 reinforce the stability of CXCL1 mRNA, we also evaluated the relationship of CXCL1 plasma levels with TRAF3IP2 genotypes in patients.</s><s>Second, they were asked and examined for recent infectious diseases including common cold, influenza, lung infection, urinary tract infection, brucellosis, tuberculosis, and typhoid and excluded if positive.</s><s>Third, the recipients of recent surgery and dentistry and those who were on any medications such as antibiotics, aspirin, propranolol, or had recently received any vaccine or blood products were excluded from study.</s><s>Travel to endemic malaria areas in the country, tattooing, acupuncture, high or low blood pressure and anemia, favism, and risky behaviors were also considered as exclusion criteria.</s><s>Blood samples from these individuals were further tested for infectious diseases such as hepatitis C, hepatitis B, AIDS, and syphilis.</s><s>All of these 201 peoples were negative for those criteria.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2">| METHODS AND MATERIALS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.1">| Study population</head><p><s>The lipid panel (HDL, LDL, TG, and cholesterol) and blood glucose levels were not studied due to the fact that the control individuals were not fasting.</s><s>Having said so, we only included individuals who had their lipid profile and blood sugar levels checked up to 3 months before sampling and turned normal.</s></p><p><s>Body mass index (BMI) was calculated as weight in kilograms divided by height in square meters.</s><s>Hypertension was defined as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure ≥90 mm Hg or the use of oral antihypertensive therapy.</s><s>Type 2 diabetes mellitus (T2DM) was diagnosed according to World Health Organization criteria. <ref type="bibr" target="#b17">17</ref></s><s>Hyperlipidemia was defined as elevated levels of any or all lipids and/or lipoproteins in the blood.</s><s>The concentration of DNA samples was standardized to 0.3 μg/μL.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="2.3">| Genotyping</head><p><s>We studied two SNPs in TRAF3IP2 gene: one coding polymorphism</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3">| RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.1">| Genotype distributions and allelic prevalence</head><p><s>The genotype distributions and allelic prevalence of studied SNPs are shown in Table <ref type="table">3</ref>.</s><s>Two studied SNPs in patient and control groups followed Hardy-Weinberg equilibrium.</s><s>As indicated in Table <ref type="table">3</ref>, TRAF3IP2 (rs33980500) and TRAF3IP2 (rs13210247) SNPs showed no significant difference in allelic and genotype distributions between patients and controls (Table <ref type="table">3</ref>).</s><s>Moreover, logistic binary regression after correction for sex and age confirmed the results of chi-square showing that TRAF3IP2 rs13210247 and rs33980500 alleles (P = .</s><s>The analysis of TRAF3IP2 (rs33980500) and TRAF3IP2 (rs13210247) haplotypes was performed by LD2SNPing v2.0 and statistical EPI-INFO 7 softwares.</s><s>There was no significant difference between healthy individuals and patients with MI in respect to TRAF3IP2 (rs33980500) and TRAF3IP2 (rs13210247) haplotypes (Table <ref type="table">4</ref>, P = .05).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.2">| Associations of TRAF3IP2 (rs33980500) and TRAF3IP2 (rs13210247) genes variants with clinicopathologic characteristics of patients</head><p><s>T allele and TT genotype in TRAF3IP2 (rs33980500) polymorphism were associated with female gender, diastolic dysfunction, mechanical complications of heart, left main artery stenosis, anterolateral hypokinesis, and left ventricular ejection fraction; however, CT genotype was associated with positive family history of the diseases.</s><s>Binary regression analysis confirmed the association of T allele with gender (P = .043,</s><s>OR = 2.24), family history of cardiovascular disease (P = .024,</s><s>OR = 2.30), diastolic dysfunction (P = .01,</s><s>OR = 3.76), mechanical complications of the heart (P = .01,</s><s>OR = 2.7), and left main artery stenosis (P &lt; .0001,</s><s>OR = 31.033)</s><s>(Table <ref type="table">5</ref>).</s></p><p><s>Also binary regression analysis confirmed the association of the G allele of TRAF3IP2 rs13210247 with the mechanical complications of the heart (P = .01,</s><s>OR = 3.29), but in spite of the primary analysis, correlation with left main artery stenosis (P = .06,</s><s>OR = 2.826) and diastolic dysfunction did not reach the significant level (P = .06,</s><s>OR = 4.27) (Table <ref type="table">6</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.3">| Comparison of CXCL1 plasma levels between patients and controls</head><p><s>In this study, plasma levels of CXCL1 in 126 patients and 50 controls were measured.</s><s>Due to the lack of normal distribution in data, approved by Kolmogorov-Smirnov and Shapiro-Wilk statistical tests, we used the nonparametric Mann-Whitney test for comparison between groups.</s><s>Statistical analysis showed a significant difference in the plasma levels of CXCL1 chemokine between MI patients and healthy controls (P = .0006,</s><s>Figure <ref type="figure">3</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="3.4">| Associations between TRAF3IP2 (rs33980500) and (rs13210247) variants and CXCL1 chemokine levels</head><p><s>We investigated the association between plasma levels of CXCL1 chemokine with studied polymorphisms in patients and controls.</s><s>Due to the low number of patients in each cluster of genotypes and high variance in the plasma levels of CXCL1, we used Kruskal-Wallis test for data analysis.</s><s>We found a significant correlation between plasma contents of CXCL1 and TT genotype of TRAF3IP2 (rs33980500) polymorphism in patients (P = .04,</s><s>Figure <ref type="figure" target="#fig_3">4A</ref>).</s></p><p><s>We also studied the association between plasma levels of CXCL1 and TRAF3IP2 (rs13210247) polymorphism in the healthy controls and MI patients.</s><s>There again we observed non-significantly higher plasma levels of CXCL1 chemokine and the two patients with GG genotype (P = .056,</s><s>Figure <ref type="figure" target="#fig_3">4B</ref>).</s><s>However, the low number of patients in this group decreased the power of this result.</s></p><p><s>T A B L E 3 The distribution of studied SNPs genotypes and allelic frequencies in the MI patients and the controls</s></p><p><s>&gt;35</s></p><p><s>T A B L E 5 (Continued)</s></p><p><s>In our study, the highest correlation was observed between the risk allele of TRAF3IP2 rs33980500 with left main coronary artery stenosis.</s></p><p><s>Few studies have investigated the inflammatory processes in left main coronary artery stenosis among which a recent one showed a positive correlation between serum Chemerin, as an inflammatory marker, and the degree of stenosis. <ref type="bibr" target="#b18">18</ref></s><s>is mutant/risk allele is reported to be associated with increased inflammation. <ref type="bibr" target="#b19">19</ref></s><s>Inflammation reduces nitric oxide, cyclic guanosine, and activity of protein kinase G which lead to increase in myocardial hypertrophy and increased resting due to hypo phosphorylation of the cytoskeletal protein, titin, that can lead to a decrease in cardiac output. <ref type="bibr" target="#b20">20</ref></s><s>Moreover, high serum levels of CRP along with leukocyte count are reported to predict poor outcome in patients with unprotected left main coronary artery stenosis. <ref type="bibr" target="#b21">21,</ref><ref type="bibr" target="#b22">22</ref></s><s> also found significantly increased mutant/risk alleles of TRAF3IP2 (rs33980500, rs13210247) in MI patients with diastolic dysfunction compared with other patients.</s><s>Myocardial infarction leads to loss of contractility and impairment of heart ventricular dilation resulting in reduction of systolic and diastolic function.</s><s>to slip myocytes, thin walls, increased wall stress, ventricular dilatation, and eventually ventricular septal rupture.</s><s>The incidence of these three mechanical effects is very low, but is associated with very poor prognosis. <ref type="bibr" target="#b28">28</ref></s><s>Previous studies have shown that western diet increases the expression of TRAF3IP2 in mice <ref type="bibr" target="#b29">29</ref> and male transgenic mice with cardiomyocyte-specific TRAF3IP2 overexpression develop spontaneous myocardial hypertrophy, fibrosis, and dysfunction where a gender-dependent effect of TRAF3IP2 is suggested. <ref type="bibr" target="#b30">30</ref></s><s>In addition, dipeptidyl peptidase-4 inhibition results in simultaneous reduction of TRAF3IP2, proinflammatory cytokine, and growth factor expression, as well as collagen induction in primary cardiac fibroblasts. <ref type="bibr" target="#b29">29</ref></s><s>This phenomenon which reverses diastolic dysfunction through targeting TRAF3IP2 expression and its downstream inflammatory signaling has cardioprotective effects. <ref type="bibr" target="#b29">29</ref></s><s> observed an increase in the mutant/risk allele of TRAF3IP2 (rs33980500) in MI patients with anterolateral hypokinesia.</s></p><p><s>Hypokinesia is defined as less movement in parts of heart walls within each heartbeat.</s><s>An inadequate blood supply leads to wall motion abnormalities, a condition such as myocardial infarction.</s><s>Hypokinesia can reduce ejection fraction, cardiac output, and even cause organ failure.</s><s>Patients with wall motion abnormality have lower cardiac output and higher CRP than individuals without the disorder. <ref type="bibr" target="#b31">31</ref></s><s>In our study, there was a trend of increase in T allele and TT genotype in patients with lower EFs (Table <ref type="table">5</ref>).</s><s>This observation is noteworthy because rs33980500 results in the substitution of an asparagine for an aspartic acid at position 10 of ACT1, which due to alternative splicing of its mRNA two ACT1 isoforms with different functionality are produced in fibroblasts but not in T cells. <ref type="bibr" target="#b32">32</ref></s><s>Therefore, fibroblasts remain responsive to IL-17A and its signaling.</s><s>Once again, these results underline the significance of TRAF3IP2 gene variants and its protein regulation in different diseases.</s></p><p><s>Our finding showed an increase in the mutant/risk allele of TRAF3IP2 (rs33980500) polymorphism in female patients.</s><s>It is known that the clinical signs, treatment, diagnosis, and prognosis of cardiovascular disease in men and women are different. <ref type="bibr" target="#b33">33,</ref><ref type="bibr" target="#b34">34</ref></s><s>Previous studies have shown more deaths among women than men after MI. <ref type="bibr" target="#b35">35</ref> Our results once again highlight the gender differences in genetics of myocardial infarction.</s></p><p><s>In this study, also we compared the plasma levels of CXCL1 chemokine between patients with MI and healthy subjects, and investigated the correlation between different genotypes of TRAF3IP2 polymorphisms and the plasma levels of CXCL1 in MI patients and healthy controls.</s><s>CXCL1 is one of the target genes of IL-17A signaling pathway, levels of which may be affected by functional polymorphisms in TRAF3IP2 adaptor in this pathway.</s><s>Elevated level of CXCL1 in patients with myocardial infarction is already reported. <ref type="bibr" target="#b7">7,</ref><ref type="bibr" target="#b36">36,</ref><ref type="bibr" target="#b37">37</ref></s><s>However, the interesting finding was the significant correlation between TT genotype of TRAF3IP2 (rs33980500) and plasma levels of CXCL1 in MI patients.</s><s>TT genotype reinforces the IL-17A signaling pathway in a direction, which leads to the stability of CXCL1 mRNA and by this mechanism may have led to increased levels of CXCL1 in the blood.</s></p><p><s>Our study had limitations in terms of cost and logistics for expanding sample size (which affected the power of study, especially for rs13210247 alleles) as well as testing lipid profile and blood sugar, blood pressure, and BMI of control individuals at the time of sampling.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head n="5">| CONCLUSION</head><p><s>Our study showed no significant difference in the genotype distributions and allelic prevalence between cases and controls, however, we observed associations between mutant/risk alleles of studied polymorphisms of TRAF3IP2 and correlates of poor prognosis of MI.</s></p><p><s>TRAF3IP2 is the coding gene of Act1 adaptor molecule in the IL-17A signaling pathway which is increasingly known to be a main player in the pathogenic inflammation of various diseases.</s><s>Our results reemphasize the role of inflammatory genetic factors in the coronary artery diseases and may provide information to identify molecules that can be targeted in therapeutic approaches.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head></head><label></label><figDesc><div><p><s>All confirmed MI cases (n = 201) referring to the affiliated hospitals of Shiraz University of Medical Sciences in a 1-year period were included in this study.</s><s>MI diagnosis was approved by collaborating cardiologist on the basis of typical ECG changes and increased cardiac markers.</s><s>The MI diagnosis was confirmed by coronary angiography.</s><s>The patients' clinical and pathological criteria are shown in</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>2. 2 |</head><label>2</label><figDesc><div><p><s>Blood samples and DNA extraction Venous blood of 6 ml was collected from all subjects in tubes containing ethylene diamine tetra acetic acid (EDTA) anticoagulant in the first 12 hours after admission.</s><s>Plasma was separated for ELISA test within an hour after blood collection and DNA extraction was further performed by salting out method.</s><s>DNA concentration and protein contamination were determined by means of spectrophotometer in 260 and 280 wavelength.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head></head><label></label><figDesc><div><p><s>rs33980500 and an intronic one called rs13210247.</s><s>PCR and RFLP methods were established and used for genotyping of noted SNPs.</s><s>PCR procedure was performed in a 15 μL total reaction volume containing 200 μM of each dNTPs, 300 ng genomic DNA, 2 mM of MgCl 2 , 10X PCR Buffer, 1U Taq DNA polymerase, and 1.0 μM of each primer.</s><s>Then, the related restriction enzyme was added to PCR products and incubated at 37°C overnight in a dry block.</s><s>The primers sequences, required restriction enzyme, recognition site of restriction enzyme, and length of cleaved products are shown in Table2.</s><s>The enzymatically cleaved products were electrophoresed on a 3.5 agarose gel containing 2.5 μL safe stain and visualized by UV light at 254 nm (Figures1 and 2).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>2. 4 |</head><label>4</label><figDesc><div><p><s>Cytokine measurement CXCL1 plasma levels in 126 MI patients and 50 normal subjects were measured by the Human CXCL1 (MGSA alpha, Thermo scientific, USA) ELISA assay.</s><s>Due to financial inadequacies, chemokine measurement was not performed in all patients and healthy individuals.</s><s>Selected patients and healthy controls representing different genotypes were included in this assay.</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>F</head><label></label><figDesc><div><p><s>35 and P = .31,</s><s>respectively) and genotypes (P &gt; .05</s><s>for all genotypes) do not increase the susceptibility to myocardial infarction.</s><s>The analysis based on dominant, recessive, and additive models showed no increase in the T A B L E 2 Primer sequences, restriction endonucleases, PCR product lengths, and restriction patterns I G U R E 1 PCR-RFLP products corresponding to the TRAF3IP2 rs33980500 polymorphism F I G U R E 2 PCR-RFLP products corresponding to the TRAF3IP2 rs13210247 polymorphism susceptibility to myocardial infarction by the mutant genotypes (data not shown).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head></head><label></label><figDesc><div><p><s>Physiological phase diastolic function including active relaxation and passive filling are both affected by myocardial ischemia and myocardial infarction.</s><s>Active relaxation after a heart attack is postponed, while changes in left ventricular stiffness depend on the rate of myocardial infarction and remodeling after myocardial infarction.</s><s>Interstitial edema and fibrosis increase the stiffness of the ventricle wall.</s><s>MI patients with diastolic dysfunction have poorer prognosis compared with MI patient without diastolic dysfunction. 23-25</s><s>Therefore, the increased frequencies of TRAF3IP2 inflammatory variants in patients may be considered as a correlate of poor prognosis.</s><s>The increase in the same mutant/risk alleles of TRAF3IP2 in patients with left main coronary artery stenosis is in line with this suggestion.</s><s>Many studies show the role of inflammation in atherosclerotic plaque formation, atherosclerosis progression, and narrowing of the arteries. 26,27</s><s>Interestingly, we observed an increase in the frequencies of mutant/risk alleles of TRAF3IP2 (rs33980500, rs13210247) in patients with ventricular septal rupture (VSR).</s><s>Mechanical complications of myocardial infarction include ventricular septal rupture, free wall rupture, and ischemic mitral regurgitation.</s><s>Mechanical complications F I G U R E 3 Comparison of CXCL1 chemokine plasma levels between MI patients and healthy controls F I G U R E 4 The functional relevance of the studied TRAF3IP2 SNPs on CXCL1 chemokine production.</s><s>(A) The plasma levels of CXCL1 (pg/mL) compared between patients and controls based on the TRAF3IP2 rs33980500 genotype.</s><s>(B) The plasma levels of CXCL1 (pg/mL) compared between patients and controls based on the TRAF3IP2 rs13210247 genotype after a heart attack occur due to the lack of proper blood flow which leads to myocardial necrosis, neutrophil infiltration, activation of MMPs, and degradation of collagen by serine proteases which lead</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head>Table</head><label></label><figDesc></figDesc><table /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_2"><head></head><label></label><figDesc><div><p><s>. Control individuals (n = 201) were selected from among healthy blood donors of the same age range and gender (mean</s></p></div></figDesc><table /><note><p><s>age ± SD = 57.80 ± 11.8 years, 175 Male/26 Female) who referred to Fars Blood Transfusion Center.</s><s>First, they were examined by a physician and were evaluated for underlying diseases, including: cardiovascular diseases, hyperthyroidism, hypertension, pulmonary diseases, stroke, diabetes, cancer, and autoimmune diseases.</s></p></note></figure>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ACKNOWLEDGMENTS</head><p><s>This work was performed as part of Safoora Pordel dissertation as a requirement for graduation as a M.Sc. of Immunology from Shiraz School of Medicine (Shiraz, Iran).</s><s>This project was financially supported by grants (93-7394 and 94-10213) from Shiraz University of Medical Sciences, Shiraz, Iran.</s><s>No writing assistance was utilized in the production of this manuscript.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>ORCID</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Mehrnoosh Doroudchi</head><p><s>http://orcid.org/0000-0003-4067-5400</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<ptr target="http://www.qmedicine.co.in/top%20health%20topics/H/Myocardial%20" />
		<title level="m">Myocardial Infarction (Heart Attack)2015 Available from</title>
				<imprint/>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<monogr>
		<title level="m" type="main">Infarction%20(Heart%20Attack).html/. Accessed 4</title>
		<imprint>
			<date type="published" when="2017-12">December 2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Monocytes: protagonists of infarct inflammation and repair after myocardial infarction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Nahrendorf</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Pittet</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">K</forename><surname>Swirski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">121</biblScope>
			<biblScope unit="page" from="2437" to="2445" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Ischemia and reperfusion [mdash] from mechanism to translation</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Eltzschig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Eckle</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">17</biblScope>
			<biblScope unit="page" from="1391" to="1401" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Interleukin-17 in atherosclerosis and cardiovascular disease: the good, the bad, and the unknown</title>
		<author>
			<persName><forename type="first">G</forename><surname>Liuzzo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Trotta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Pedicino</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur Heart J</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="556" to="559" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Myeloperoxidase (MPO) and interleukin-17 (IL-17) plasma levels are increased in patients with acute coronary syndromes</title>
		<author>
			<persName><forename type="first">J</forename><surname>Liang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Wang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Int Med Res</title>
		<imprint>
			<biblScope unit="volume">37</biblScope>
			<biblScope unit="page" from="862" to="866" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">IL-17A levels increase in the infarcted region of the left ventricle in a rat model of myocardial infarction</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Ávalos</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">A</forename><surname>Apablaza</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Quiroz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biol Res</title>
		<imprint>
			<biblScope unit="volume">45</biblScope>
			<biblScope unit="page" from="193" to="200" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">Enhanced IL-17 signalling following myocardial ischaemia/reperfusion injury</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">P</forename><surname>Barry</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ounzain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Mccormick</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Int J Cardiol</title>
		<imprint>
			<biblScope unit="volume">163</biblScope>
			<biblScope unit="page" from="326" to="334" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">A fresh look at reperfusion injury</title>
		<author>
			<persName><forename type="first">H</forename><surname>Piper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Garcña-Dorado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ovize</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Res</title>
		<imprint>
			<biblScope unit="volume">38</biblScope>
			<biblScope unit="page" from="291" to="300" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Myocardial reperfusion injury</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Yellon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">J</forename><surname>Hausenloy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">357</biblScope>
			<biblScope unit="page" from="1121" to="1135" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Interleukin 17 treatment prolongs CXCL1 mRNA half-life via TRAF5 and the splicing regulatory factor SF2/ASF</title>
		<author>
			<persName><forename type="first">D</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Novotny</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Bulek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hamilton</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="853" to="860" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Recent advances in the IL-17 cytokine family</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Gaffen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Immunol</title>
		<imprint>
			<biblScope unit="volume">23</biblScope>
			<biblScope unit="page" from="613" to="619" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">IL-17 signaling in host defense and inflammatory diseases</title>
		<author>
			<persName><forename type="first">Y</forename><surname>Qian</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Kang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cell Mol Immunol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="328" to="333" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">The adaptor protein CIKS/ACT1 is necessary for collagen-induced arthritis, and it contributes to the production of collagen-specific antibody</title>
		<author>
			<persName><forename type="first">P</forename><surname>Pisitkun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Claudio</forename><forename type="middle">E</forename><surname>Ren</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Siebenlist</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="3334" to="3344" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Function of Act1 in IL-17 family signaling and autoimmunity</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Zepp</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Adv Exp Med Biol</title>
		<imprint>
			<biblScope unit="volume">946</biblScope>
			<biblScope unit="page" from="223" to="235" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease</title>
		<author>
			<persName><forename type="first">C</forename><surname>Ciccacci</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Biancone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Di</forename><surname>Fusco</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Crohns Colitis</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page" from="44" to="52" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Genome-wide association study identifies a psoriasis susceptibility locus at TRAF3IP2</title>
		<author>
			<persName><forename type="first">E</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Ellinghaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">E</forename><surname>Stuart</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Genet</title>
		<imprint>
			<biblScope unit="volume">42</biblScope>
			<biblScope unit="page" from="991" to="995" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Interleukin-17A gene haplotypes are associated with risk of premature coronary artery disease in Mexican patients from the Genetics of Atherosclerotic Disease (GEA) study</title>
		<author>
			<persName><forename type="first">G</forename><surname>Vargas-Alarcón</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Angeles-Martínez</forename></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Villarreal-Molina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS ONE</title>
		<imprint>
			<biblScope unit="volume">10</biblScope>
			<biblScope unit="page">e0114943</biblScope>
			<date type="published" when="2015">2015</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Relationship between Chemerin Levels and Cardiometabolic Parameters and Degree of Coronary Stenosis in Korean Patients with Coronary Artery Disease</title>
		<author>
			<persName><forename type="first">Yjkn</forename><surname>Hah</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">S</forename><surname>Kim</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Diabetes Metab J</title>
		<imprint>
			<biblScope unit="volume">35</biblScope>
			<biblScope unit="page" from="248" to="254" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">New insight into the functions of the interleukin-17 receptor adaptor protein Act1 in psoriatic arthritis</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Doyle</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><forename type="middle">M</forename><surname>Fitzgerald</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">R</forename><surname>Pennington</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Res Ther</title>
		<imprint>
			<biblScope unit="volume">14</biblScope>
			<biblScope unit="page">226</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">J</forename><surname>Paulus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Tschöpe</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="263" to="271" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Preprocedural levels of C-reactive protein and leukocyte counts predict 9-month mortality after coronary angioplasty for the treatment of unprotected left main coronary artery stenosis</title>
		<author>
			<persName><forename type="first">T</forename><surname>Palmerini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Marzocchi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Marrozzini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">112</biblScope>
			<biblScope unit="page" from="2332" to="2338" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">Predictive value of coronary artery stenoses and C-reactive protein levels in patients with stable coronary artery disease</title>
		<author>
			<persName><forename type="first">Rap</forename><surname>Arroyo-Espliguero</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Quiles</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">C</forename><surname>Kaski</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Atherosclerosis</title>
		<imprint>
			<biblScope unit="volume">204</biblScope>
			<biblScope unit="page" from="239" to="243" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Echo-Doppler evaluation of left ventricular diastolic dysfunction during acute myocardial infarction: methodological, clinical and prognostic implications</title>
		<author>
			<persName><forename type="first">G</forename><surname>Cerisano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bolognese</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ital Heart J</title>
		<imprint>
			<biblScope unit="volume">2</biblScope>
			<biblScope unit="page" from="13" to="20" />
			<date type="published" when="2001">2001</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Evolving focus on diastolic dysfunction in patients with coronary artery disease</title>
		<author>
			<persName><forename type="first">T</forename><surname>Ohara</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">C</forename><surname>Little</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Opin Cardiol</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="613" to="621" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Left ventricular diastolic function following myocardial infarction</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Thune</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Solomon</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Heart Fail Rep</title>
		<imprint>
			<biblScope unit="volume">3</biblScope>
			<biblScope unit="page" from="170" to="174" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Inflammation and atherosclerosis</title>
		<author>
			<persName><forename type="first">P</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ridker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Maseri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="1135" to="1143" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">Inflammation in atherosclerosis: from pathophysiology to practice</title>
		<author>
			<persName><forename type="first">P</forename><surname>Libby</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">M</forename><surname>Ridker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">K</forename><surname>Hansson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Am Coll Cardiol</title>
		<imprint>
			<biblScope unit="volume">54</biblScope>
			<biblScope unit="page" from="2129" to="2138" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Myocardial infarct expansion, infarct extension, and reinfarction: pathophysiologic concepts</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">F</forename><surname>Weisman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Healy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Cardiovasc Dis</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page" from="73" to="110" />
			<date type="published" when="1987">1987</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Dipeptidyl peptidase-4 (DPP-4) inhibition with linagliptin reduces western diet-induced myocardial TRAF3IP2 expression, inflammation and fibrosis in female mice</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">R</forename><surname>Aroor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Habibi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">K</forename><surname>Kandikattu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Cardiovasc Diabetol</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page">61</biblScope>
			<date type="published" when="2017">2017</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">Cardiac-restricted Overexpression of TRAF3 Interacting Protein 2 (TRAF3IP2) Results in Spontaneous Development of Myocardial Hypertrophy, Fibrosis, and Dysfunction</title>
		<author>
			<persName><forename type="first">M</forename><surname>Yariswamy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Yoshida</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">J</forename><surname>Valente</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">291</biblScope>
			<biblScope unit="page" from="19425" to="19436" />
			<date type="published" when="2016">2016</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Prevalence and Prognostic Significance of Wall-Motion Abnormalities in Adults Without Clinically Recognized Cardiovascular Disease The Strong Heart Study</title>
		<author>
			<persName><forename type="first">S</forename><surname>Cicala</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>De Simone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Roman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Circulation</title>
		<imprint>
			<biblScope unit="volume">116</biblScope>
			<biblScope unit="page" from="143" to="150" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The differential regulation of human ACT1 isoforms by Hsp90 in IL-17 signaling</title>
		<author>
			<persName><forename type="first">L</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Wang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Boisson</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">193</biblScope>
			<biblScope unit="page" from="1590" to="1599" />
			<date type="published" when="2014">2014</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">Gender differences in coronary heart disease</title>
		<author>
			<persName><forename type="first">A</forename><surname>Maas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Appelman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Neth Heart J</title>
		<imprint>
			<biblScope unit="volume">18</biblScope>
			<biblScope unit="page" from="598" to="603" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Diagnosis and treatment of heart disease: are women different from men?</title>
		<author>
			<persName><forename type="first">B</forename><surname>Xhyheri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Bugiardini</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Prog Cardiovasc Dis</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="227" to="236" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Ischemic heart disease in women</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">E</forename><surname>Ashley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Geraci</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">South Med J</title>
		<imprint>
			<biblScope unit="volume">106</biblScope>
			<biblScope unit="page" from="427" to="433" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">Structureactivity relationships of interleukin-8 determined using chemically synthesized analogs. Critical role of NH2-terminal residues and evidence for uncoupling of neutrophil chemotaxis, exocytosis, and receptor binding activities</title>
		<author>
			<persName><forename type="first">Clark-Lewis I</forename><surname>Schumacher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Baggiolini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Moser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">266</biblScope>
			<biblScope unit="page" from="23128" to="23134" />
			<date type="published" when="1991">1991</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">Neutrophil chemoattractants generated in two phases during reperfusion of ischemic myocardium in the rabbit. Evidence for a role for C5a and interleukin-8</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Ivey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">M</forename><surname>Williams</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">D</forename><surname>Collins</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Jose</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Williams</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Clin Invest</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page">2720</biblScope>
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
